Artelo Biosciences Inc. (NASDAQ: ARTL) is -74.11% lower on its value in year-to-date trading and has touched a low of $0.45 and a high of $4.42 in the current 52-week trading range. The ARTL stock was last observed hovering at around $0.64 in the last trading session, with the day’s gains setting it 0.06% off its average median price target of $8.00 for the next 12 months. It is also 91.25% off the consensus price target high of $8.00 offered by 1 analysts, but current levels are 91.25% higher than the price target low of $8.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $0.70, the stock is 10.59% and 20.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.75 million and changing 9.27% at the moment leaves the stock -28.01% off its SMA200. ARTL registered -74.11% loss for a year compared to 6-month loss of -44.09%. The firm has a 50-day simple moving average (SMA 50) of $0.6008 and a 200-day simple moving average (SMA200) of $0.8900.
The stock witnessed a 13.77% gain in the last 1 month and extending the period to 3 months gives it a -29.59%, and is 11.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.26% over the week and 10.80% over the month.
Distance from 52-week low is 54.97% and -84.20% from its 52-week high.
Artelo Biosciences Inc. (ARTL) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Artelo Biosciences Inc. (ARTL) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Artelo Biosciences Inc. is expected to release its quarterly report on 04/20/2021 and quarterly earnings per share for the current quarter are estimated at -$0.38.The EPS is expected to shrink by -25.60% this year.
Artelo Biosciences Inc. (ARTL) Top Institutional Holders
8 institutions hold shares in Artelo Biosciences Inc. (ARTL), with 1.74M shares held by insiders accounting for 11.48% while institutional investors hold 32.60% of the company’s shares. The shares outstanding are 15.11M, and float is at 10.37M with Short Float at 5.72%. Institutions hold 28.85% of the Float.